These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Brivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program. Brodie MJ; Fakhoury T; McDonough B; Colson AO; Stockis A; Elmoufti S; Whitesides J Epilepsy Res; 2018 Sep; 145():55-62. PubMed ID: 29908435 [TBL] [Abstract][Full Text] [Related]
27. Fluctuations of carbamazepine concentrations during the day for two slow-release preparations. May T; Rambeck B Ther Drug Monit; 1989; 11(1):21-4. PubMed ID: 2911848 [TBL] [Abstract][Full Text] [Related]
28. Acute oral loading of carbamazepine-CR and phenytoin in a double-blind randomized study of patients at risk of seizures. Van Der Meyden CH; Kruger AJ; Müller FO; Rabie W; Schall R Epilepsia; 1994; 35(1):189-94. PubMed ID: 8112244 [TBL] [Abstract][Full Text] [Related]
29. A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients. Patsalos PN Br J Clin Pharmacol; 1990 May; 29(5):574-7. PubMed ID: 2350535 [TBL] [Abstract][Full Text] [Related]
30. Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy. Schoeman JF; Elyas AA; Brett EM; Lascelles PT Dev Med Child Neurol; 1984 Dec; 26(6):756-64. PubMed ID: 6440825 [TBL] [Abstract][Full Text] [Related]
31. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy. Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690 [TBL] [Abstract][Full Text] [Related]
33. Adjustment of carbamazepine dose to offset the effects of the interaction with remacemide hydrochloride in a double-blind, multicentre, add-on drug trial (CR2237) in refractory epilepsy. Mawer GE; Jamieson V; Lucas SB; Wild JM Epilepsia; 1999 Feb; 40(2):190-6. PubMed ID: 9952266 [TBL] [Abstract][Full Text] [Related]
34. Intradose and circadian variation in circulating carbamazepine and its epoxide in epileptic patients: a consequence of autoinduction of metabolism. Macphee GJ; Butler E; Brodie MJ Epilepsia; 1987; 28(3):286-94. PubMed ID: 3582293 [TBL] [Abstract][Full Text] [Related]
35. Double-blind crossover comparison of Tegretol-XR and Tegretol in patients with epilepsy. The Tegretol OROS Osmotic Release Delivery System Study Group. Neurology; 1995 Sep; 45(9):1703-7. PubMed ID: 7675230 [TBL] [Abstract][Full Text] [Related]
36. Factors influencing simultaneous concentrations of total and free carbamazepine and carbamazepine-10, 11-epoxide in serum of children with epilepsy. Elyas AA; Patsalos PN; Agbato OA; Brett EM; Lascelles PT Ther Drug Monit; 1986; 8(3):288-92. PubMed ID: 3750372 [TBL] [Abstract][Full Text] [Related]
37. Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients. Macphee GJ; McPhail EM; Butler E; Brodie MJ Eur J Clin Pharmacol; 1986; 31(2):195-9. PubMed ID: 3803416 [TBL] [Abstract][Full Text] [Related]
38. Unblinded, randomized multicenter trial comparing lamotrigine and valproate combination with controlled-release carbamazepine monotherapy as initial drug regimen in untreated epilepsy. Lee BI; No SK; Yi SD; Lee HW; Kim OJ; Kim SH; Kim MK; Kim SE; Kim YS; Kim JM; Lee SJ; Shin DJ; Park SP; Kim YI; Heo K; Cho YW; Cho YJ; Kim YN Seizure; 2018 Feb; 55():17-24. PubMed ID: 29324401 [TBL] [Abstract][Full Text] [Related]
39. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A; CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527 [TBL] [Abstract][Full Text] [Related]